Monday, 21 April 2014

FIIs increase stake in Dr Reddy’s Lab during March quarter

Foreign Institutional Investors (FIIs) have raised their stake in Dr Reddy’s Laboratories, an integrated global pharmaceutical company to 34.30% at the end of March 2014 quarter from 33.35% as on December 31, 2013.
On the other hand, domestic institutional investors’ (DIIs) shareholding has decreased to 6.29% at the end of March 2014 quarter from 7.54% as on December 31, 2013. Under DIIs, mutual funds / UTI held maximum stake of 4.89%, followed by insurance companies (1.34 % stake) and Financial Institutions / Banks (0.06 stake).
Meanwhile, promoter and promoter group shareholding was unchanged at 25.52% at the end of March 2014 quarter.
Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

No comments:

Post a Comment